Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tobramycin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tobramycin 80mg/2ml solution for injection vials
0501040U0AAACAC
|
Tobramycin (Systemic) | Tobramycin | Infections | 109 |
|
Tobramycin 300mg/5ml nebuliser liquid ampoules
0501040U0AAAGAG
|
Tobramycin (Systemic) | Tobramycin | Infections | 81 |
|
Tobramycin 300mg/4ml nebuliser liquid ampoules
0501040U0AAAKAK
|
Tobramycin (Systemic) | Tobramycin | Infections | 32 |
|
Bramitob 300mg/4ml nebuliser solution 4ml ampoules
0501040U0BDAAAK
|
Bramitob | Tobramycin | Infections | 12 |
|
Tobramycin 40mg/1ml solution for injection vials
0501040U0AAABAB
|
Tobramycin (Systemic) | Tobramycin | Infections | 4 |
|
Tobi 300mg/5ml nebuliser solution 5ml ampoules
0501040U0BCAAAG
|
Tobi | Tobramycin | Infections | 3 |
|
Tobramycin 28mg inhalation powder capsules with device
0501040U0AAALAL
|
Tobramycin (Systemic) | Tobramycin | Infections | 3 |
|
Nebcin 80mg/2ml solution for injection vials
0501040U0BBACAC
|
Nebcin | Tobramycin | Infections | 2 |
|
Tobi Podhaler 28mg inhalation powder capsules with device
0501040U0BCABAL
|
Tobi | Tobramycin | Infections | 2 |
|
Tobramycin 40mg/5ml oral solution
0501040U0AAAHAH
|
Tobramycin (Systemic) | Tobramycin | Infections | 2 |
|
Tymbrineb 300mg/5ml nebuliser solution 5ml ampoules
0501040U0BFAAAG
|
Tymbrineb | Tobramycin | Infections | 2 |
|
Munuza 300mg/5ml nebuliser solution 5ml ampoules
0501040U0BHAAAG
|
Munuza | Tobramycin | Infections | No data available |
|
Nebcin 20mg/2ml solution for injection vials
0501040U0BBAAAA
|
Nebcin | Tobramycin | Infections | No data available |
|
Tobramycin 170mg/1.7ml nebuliser liquid ampoules
0501040U0AAANAN
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 20mg/2ml solution for injection vials
0501040U0AAAAAA
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 20mg/5ml oral solution
0501040U0AAAMAM
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 240mg/6ml solution for injection vials
0501040U0AAAIAI
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 3mg/ml eye drops
1103010X0AAAAAA
|
Tobramycin (Eye) | Tobramycin | Eye | No data available |
|
Tobramycin 40mg/1ml solution for injection ampoules
0501040U0AAAEAE
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 80mg/2ml solution for infusion ampoules
0501040U0AAAFAF
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobravisc 3mg/ml eye drops
1103010X0BCAAAA
|
Tobravisc | Tobramycin | Eye | No data available |
|
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules
0501040U0BGAAAN
|
Vantobra | Tobramycin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.